Triple Negative Breast Cancer Biomarker Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01111175
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : July 23, 2013
Translational Drug Development
Life Technologies, Inc.
Information provided by (Responsible Party):
US Oncology Research

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : June 2013